Positive Testimonials
Inuspheresis, a form of therapeutic apheresis that filters blood plasma to remove toxins, inflammatory markers, autoantibodies, and other substances, has received praise from some patients, particularly those with Long COVID, ME/CFS, or cognitive issues. Here are selected positive experiences drawn from patient reports and studies:
- Full recovery from Long COVID after two sessions: A patient who suffered for two years reported being "100% healthy" over a year post-treatment, including resuming work, socializing, climbing 3-4 times a week, and multi-day hikes with normal recovery. They attributed success to prior blood thinners and noted microclots and autoantibodies were present pre-treatment. Similar accounts describe a significant energy boost after initial fatigue, with full effects emerging over 4 months alongside stress reduction.
- Dramatic cognitive improvement in Alzheimer's-like symptoms: A patient's mother, previously unable to speak in full sentences or recognize objects, began doing so immediately after the first session. Her short-term memory improved drastically, and she started laughing and joking again.
- Early cognitive and energy gains in Long COVID: After just one session, a patient noted better mental clarity ("my head is cooperating better") and anticipated further processing time for the body. This came after two years of illness starting in December 2020.
- High success rates in clinical cohorts: In a study of 1,111 ME/CFS patients (including 13% with Long COVID), 74% reported no symptoms or significant improvement after three sessions, with 64% improved after the third and 56% after the second. A smaller Long COVID cohort (n=27) showed reduced autoantibodies, lipids, and inflammation correlating with symptom relief.
- General wellness and detoxification boost: One user called it "the only thing that truly helps" for Long COVID symptoms. Clinics report overall positive feedback, with patients feeling supported in photo/text reports.
Negative Testimonials
While some experience benefits, others report limited, temporary, or no effects, with concerns about cost (often €5,000+ for sessions), relapse, and lack of robust evidence for broad use. Negative experiences include:
- No relief from core symptoms despite sessions: A patient with Long COVID noted no improvement in muscle twitching or post-exertional malaise (PEM) after treatment, though spike antibodies dropped temporarily before rising again. They questioned if more sessions (beyond three) would help or if it was "a waste of time."
- Temporary relief followed by relapse: One individual felt symptom-free for about a week post-treatment, enabling more activities, but relapsed soon after (possibly due to travel or stress). They viewed it as a "treatment, not a cure," emphasizing upstream causes remain unaddressed. A review of German apheresis therapies (including Inuspheresis) found short-term improvements in some Long COVID patients, but often lasting only weeks.
- Worsening condition post-treatment: After two sessions in Switzerland combined with detox protocols, a patient became "very sick" within two months, describing a major setback.
- Poor outcomes at certain clinics and skepticism on efficacy: Attendees at a Cyprus EBOO/Apheresis clinic (related but distinct from Inuspheresis) reported no improvements after 12+ sessions. Critics note it's unapproved for standard diseases in Germany, operates outside conventional care, and lacks evidence for healthy individuals seeking optimization (e.g., longevity or performance). One user described temporary positives with a partner but called eluate interpretations (e.g., "dark yellow is heavy metals") "really weird" and hand-wavy.